Monday, January 5, 2009

The Sorry State of the Nation’s Health Care

Did you know that 67 percent of Americans are overweight? That 40 percent get no exercise? Or that a whopping 96 percent of Americans don’t eat enough vegetables? Even more frightening is the fact that the current generation of American children may be the first ever to have a shorter life span than their parents.

Americans paid out a record 16 percent of our GDP (or $2 trillion) for health care in 2008 … making us the world’s biggest healthcare spender, on a per capita basis, according to a recent article by TIME reporter Alice Park. Notwithstanding the huge sums we throw at the problem of health care, the U.S. is ranked 19th — last! — among industrialized nations when it comes to preventable deaths.

The biggest problem with the U.S. health-care system, Park reports, is that it has been designed to respond to illness rather than prevent it: fully half of U.S. adults in 2005 did not receive recommended preventive care. “When we do get our cardiac health checked, too often it's because we've been rushed to the emergency room suffering from chest pains. When we do get a cancer evaluation, too often it's a diagnosis of advanced disease that has spread beyond the initial tumor site,” she writes.

If our ailing healthcare system is to recover, more attention needs to be paid to education, prevention and early treatment. It’s a strategy which has been shown to deliver promising results — for example, half of adults ages 50+ and older received a colon scan, meeting the colon cancer screening targets established by the Department of Health and Human Services in its Healthy People 2010 report.

President-elect Obama is said to rank health-care reform third on his list of top priorities, just behind addressing the financial crisis and passing an energy bill. From his mouth to our legislators’ ears.

Labels: , , , , , , , ,

Tuesday, May 6, 2008

Early Ends to Positive Oncology Trials? Not Always Good News.

According to a study published recently in the Annals of Oncology, there is a growing tendency for pharmaceutical manufacturers and clinical investigators to call a premature halt to cancer drug trials the moment a benefit appears, in order to beat their competitors to market.

The Italian group analyzed 25 randomized controlled trials of oncology drugs between 1997 and 2007 — all of which were stopped early after showing some patient benefits. More than half of the trials were stopped in the past three years. Five had enrolled less than 40% of the target number of patients. The researchers warn that “the risk of overestimating treatment effects increases markedly when the sample is small.”

Paul S. Mueller, MD, an associate professor of medicine at the Mayo Clinic— who wasn’t involved with the Annals of Oncology study — concurs, saying, “Decisions are being made on some fairly shaky evidence.”

We agree with Dr. Mueller’s conclusion: “Trials should be carried out long enough in order to obtain data about outcomes important to doctors and patients.” It’s not just good public relations; it’s good public health.

Labels: , , , , , , , , , , , , , , , ,

Wednesday, April 30, 2008

Top Ten Most Useful Health Websites for Consumers

I’ve just run across a news bite that I want to share with everyone interested in obtaining accurate and reliable healthcare information for themselves and their families. It’s also a great resource for those of us who work in healthcare and pharmaceutical marketing.

The Consumer and Patient Health Information Section of the Medical Library Association has published its list of the most useful websites for healthcare consumers. Listed in alphabetical (not ranked) order, the “top ten” are:

Centers for Disease Control and Prevention (CDC)
FamilyDoctor.org
HealthFinder.gov
HIV InSite
KidsHealth
MayoClinic.com
Medem Medical Library
Medline Plus
National Cancer Institute
New York Online Access to Health (NOAH)
All of the healthcare websites were evaluated on the following criteria: credibility, sponsorship/authorship, content, audience, currency, disclosure, purpose, links, design, interactivity and disclaimers.

Labels: , , , , , , , ,